One Medical completes cup. Handle next before breakout?Will the handle form next and then the breakout?
Wait and see.
Medicalstocks
$TMDI we need a break above $1.80This has been sitting down here accumulating. This is a company getting its profit from medical patents awaiting FDA approval for its surgical technology that will increase recovery time for patients.... I'm here for it.
MODERNA POSSIBLE DISTRIBUTION!Hello my beauties.
I think MRNA has entered a distribution range, as the ST (second test) seemed to be pretty weak, and the price is now showing weakness below the trading range. We are going to wait for further developments in price action and eventually take a trade on the final LPSY. For those of you who like trading ranges, this might be a juicy opportunity. Watch for the creation of an UT (upthrust) and an UTAD (upthrust after distribution) before you take your trade.
If you find this idea to be helpful like, follow, and drop a comment below if you'd want me to analyse a different pair.
Consider supporting me if you think I am providing you with value.
Peace.
Luca, TrickleDownFX
INVITAE GOOD OPPORTUNITY Invitae offers gene panels and single-gene testing for a broad range of clinical areas including hereditary cancer, cardiology, neurology, pediatric genetics, metabolic disorders, immunology, and hematology.
The price is on a strong weekly pattern, decent long opportunity on probable bullish rebound.
ISRG consolidation then new highs or retest support?Just did a basic fib retracement on ISRG using that last low. Looks like the 50 fib line presents a consistent area of traffic and previous support. It tested the 236 fib area weeks ago and after managing to break through and hold, the stock made new highs. After failing to retest those highs at the end of the week, it settled back at the recent levels just shy of 950. That area has also been a short-term area of support. But does it hold these levels and bounce to retest ATH or is the retracement in effect heading back down closer to the 236 fib line?
Have to see what comes with ISRG earnings during this next round. That 71.22% surprise last quarter didn't hurt but can it maintain the same pace now that things are beginning to normalize to some extent?
SNY - Long After assessing Sanofi both technically and fundamentally my position on it is a strong buy.
Scenario 2 is more realistic!SNDL is maybe going to touch a new support line! Im thinking its more realistic for sndl to touch 0.6$ and then take off huge!
20-150% Profits Possible on SEEL Therapeutics My favorite new indie stock, Seelos Therapeutics, was recently upgraded from a price target of $4.70 to a whopping $15.
For this to happen, it may have to beat some bears (in SPY) and sharks (in short interest).
Short interest in the stock is down, with most shares not available to short. This is positive and bullish for shorter term.
The stock market looks to continue its rally, with minor downs, as usual, until further notice.
Biden's Infrastructure Plan may continue to stimulate the market to amazing new highs.
I may invest in this on Monday. I really need to make some $$ for food, rent, and my beloved kitten.
If it follows DLPN (Dolphin Entertainment), it may even beat its updated price target! DLPN was a rocket ship this year! Everyone go out and see some seals!
News had it that the Great White Sharks of Cape Town have disappeared this year!
Enough synchronicities, this is an ethical company that works on healing chronic diseases.
Resources:
stockinvest.us
stocktwits.com
finance.yahoo.com
www.nasdaq.com
seekingalpha.com
investorshub.advfn.com
seelostherapeutics.com
#mayweallgetrichtogether
BFLY Butterfly Network Inc"Ultrasound designed for the future."
"Experience a groundbreaking ultrasound solution and the world’s only single-probe, whole-body handheld device, powered by Ultrasound-on-Chip™ technology. Butterfly transforms complex processes into one connected POCUS system to help you offer better, more efficient care."-Butterfly Network Inc
That is info from their site
Bill gates loaded up on this stock last year
THYROCARE recently turned trend, about to test resistance zone.Hi. In this 1D chart I've plotted a few things: the recent MA 56 crossing that marked a trend turn, the approaching resistance zone from November last year and an interpretation of the movements since then as Elliott Waves.
You can also see:
There is still rooms for the Williams 224 to climb further.
The historical volatility is lower than it was in November indicating a more stable trend.
The Ichimoku is agreeing with the recent trend turn.
There is possibility that the MACD will turn down across its signal but I believe that it will either skirt the signal and then continue rising or pass below it momentarily as the current Elliott Correction Wave plays out.
It should be noted that the fundamentals of THYROCARE are absolutely excellent and therefore could be worth holding not only for the immediate future.
Thank you. Please if you have any thoughts or comments do leave them below and I would gladly discuss or adjust my interpretations and methods.
This does not constitute financial advice.
Any prices, even if explicitly stated, are presented with intent to discuss the symbol and potential interpretations.
Any trades shown or mentioned are examples and neither recommendations or mandates.
QNTA - USA BASED - Major owner of medolife.com - The King"Merging medolife
The polarization machine emits electromagnetic (EM) waves in the form of packets of quantum energy (""photons"") with a frequency that resonates with the molecular frequency of targeted compounds"
Liminal BioSciences, a risky play85% below the July peak of last year and 99% below its all-time high.
Orbiting a major support level around $4.
A capital injection began in mid-November that is still not properly reflected in price.
Stochastic at the oversold point and RSI close to touching it.
It could give the surprise of giving a significant bounce to the marked lines.
The risk is that it has been trading at a loss for some time.
"Liminal (Nasdaq: LMNL) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases that have high unmet medical need, including those related to fibrosis in respiratory, liver and kidney diseases."
Fonar Corp. in a good entryIt seems to me that it is looking for a reversal.
The price has already been rejected 2 times by touching its EMA.
It has resistance at $19.5 - 20.
30% below its August high.
It can go as high as $25.
"Fonar Corporation designs, develops, manufactures, and sells magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human disease."
NASDAQ:FONR
ALERS just bounced from a cup'n'handleEurobio-Scientific took a really good expansion doing covid tests last year.
Graphic talks for itself, enjoy the upstream :)
NOVAVAXif market keep is bullish euphorique structure, we are close to start the 3 wave that is extensive.
fundamental:
with covid trubbles and vaccination approval we can see that the probable futur trend will be bullish.
investor tend to go with hot stocks or easy to guest safe heaven sector, in the case of a global pendemie the one industry that cannot suffer from this is the medical and pharmacetical ones.
therfore the probability of a 3 wave arround the corner is really high.
also the wave 2 bounce from the 0.618 golden fib ratio, and wave 2 and 4 tend way more that just often to bounce from fib retracement. guessing a probal wave three from past support and resistance and using again the 0.618 to se were wave 4 should bounce at we have a strong probability to succes this trade.
as we know fib retracement tend to magicaly worked as resistance and support since so many investor/trader have orders at those levels.
entering now in the trade give you a stop loss at 80 so that would be 47 dollar risk/per share to a potential 120 dollar reward/ per share.
i don't know about you but i lile those kind of 3:1 reward to risk ratio.
best regards, patryck trader at richmonstocks funds.
BGNE short above 260$, target price 161$, about Mar 9, 2021.BGNE short above 260$, target price 161$, about Mar 9, 2021.
Similar pattern of Aug 8, 2018.
Wait BGNE price reached 161$, start building long position.
It's not a good idea holding BGNE under 270$~260$
Long stop-Loss price : 259$
Short stop-loss price : 284$
Healthcare Critical LevelTechnical Analysis
The 200ema has been tested several times, and has worked very well as a mid-term support level.
Risk reward ratio is easy to set-up with a 3:1 ratio approximately.
Sector & Industry Analysis
It is important to note that the industries inside the sector have different performance, which has been very useful to analyze what the market thinks of the risk of healthcare with the election coming up.
The following list is the Healthcare Industries with a 6-month performance % move, as well as a some good ETF to follow/trade:
Healthcare Technology --> +56% // have not found appropriate ETF.
Biotechnology --> +21% // XBI (smaller biotech), IBB (large-cap biotech), ARKG (genomics)
Healthcare Equipment --> +19% // IHI
Healthcare Providers --> +5.51% // IHF
Pharmaceuticals --> -1.3% // IHE
DRAD BUY (DIGIRAD CORP)Hi there. Price is forming a big reversal pattern to change its direction. Also is close to 0 value which is a very good sign.
Watch strong price action at the current levels for buy.
RMED BUY (RA MEDICAL SYSTEMS INC)Hi there. Price is forming a big reversal pattern to change its direction. Also is close to 0 value which is a very good sign.
Watch strong price action at the current levels for buy.
